Alkermes (ALKS) EBT Margin Growth (3y) (2013 - 2026)
Alkermes (ALKS) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1,840.00 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -134.00 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -1,686.00 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 12,811.00 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 5,487.00 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -225.00 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -15,283.00 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 4,514.00 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -1,162.00 |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 25,271.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15,283.00 |
| Dec 31, 2025 | -2,188.00 |
| Sep 30, 2025 | 213,081.00 |
| Jun 30, 2025 | 106,590.00 |
| Mar 31, 2025 | 2,447.00 |
| Dec 31, 2024 | 29.00 |
| Sep 30, 2024 | 3,817.00 |
| Jun 30, 2024 | 2,738.00 |
| Mar 31, 2024 | 2,081.00 |
| Dec 31, 2023 | 3,032.00 |
| Sep 30, 2023 | 2,351.00 |
| Jun 30, 2023 | 5,605.00 |
| Mar 31, 2023 | 878.00 |
| Dec 31, 2022 | 8,872.00 |
| Sep 30, 2022 | -208,415.00 |
| Jun 30, 2022 | -102,463.00 |
| Mar 31, 2022 | 2,878.00 |
| Dec 31, 2021 | 4,272.00 |
| Sep 30, 2021 | 458.00 |
| Jun 30, 2021 | 163,153.00 |